Form 4: Bausch Health CFO Jean-Jacques Charhon Awarded Restricted Share Units

EVP and CFO of Bausch Health Companies Inc., Jean-Jacques Charhon, received an award of 298,838 restricted share units on August 19, 2024.

Summary

• Jean-Jacques Charhon, the EVP and CFO of Bausch Health Companies Inc., was granted 298,838 restricted share units (RSUs) on August 19, 2024.
• These RSUs will vest in three equal installments.
• The first installment vests on the first anniversary of the grant date.
• The second installment vests on February 28, 2026.
• The third installment vests on February 28, 2027.
• Vesting is contingent upon Charhon's continued service with the company.
• Vested RSUs will be settled in common shares of Bausch Health Companies Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices, aligning management interests with shareholders. The vesting schedule promotes long-term commitment.

Positives

• The award of RSUs to the CFO aligns his interests with those of the shareholders, incentivizing him to drive long-term value for the company.

Risks

• The value of the RSUs is tied to the performance of Bausch Health Companies Inc.'s stock, which is subject to market fluctuations and company-specific risks.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Equity compensation is a common practice in the pharmaceutical and healthcare industries to attract and retain top talent and align their interests with those of shareholders.

Comparison to Industry Standards

• RSU grants are a standard form of executive compensation, comparable to practices at companies like Teva Pharmaceuticals and Mylan (now Viatris), which also utilize equity-based awards to incentivize their leadership.
• The vesting schedule of the RSUs (three equal installments over three years) is also a typical vesting arrangement seen in similar companies.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the CFO to drive company performance.
• Employees may see the grant as a sign of the company's commitment to its leadership.

Next Steps

• The reporting person will continue to hold and potentially acquire or dispose of Bausch Health securities.
• The RSUs will vest according to the specified schedule, contingent upon continued service.

Key Dates